show episodes
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, former ...
 
I
Inside Biotech

1
Inside Biotech

Dr. Yewande Pearse, Kathy Grotsch, Ananta Wadhwa

Unsubscribe
Unsubscribe
Monthly
 
Inside Biotech is an exciting new podcast from BCLA, which focuses on the science behind SoCals most innovative new biotech companies. This monthly podcast, hosted by Dr. Yewande Pearse, Media & Marketing Associate at BCLA, is the perfect way for LA’s biotech community to stay informed about current progress and developments, and features conversations with scientists, entrepreneurs, and investors about the cutting edge science that goes on inside their companies. On Inside Biotech, science ...
 
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
 
San Diego has grown into one of the largest biotechnology hubs in the United States with some very talented people doing very exciting things. Come along with me as I explore the world of biotech, meet some interesting people, and maybe even learn a thing or two. Oh wait… did I mention there will be beer?
 
Loading …
show series
 
This week on the podcast, Agustin reflects on the biotech sector and the recent price fluctuations in $XBI and highlights while there are several zombie companies that don't have long term potential. Despite these circumstances, $AFMD and $LPTX are exceptions that warrant more capital. Additionally, he reflects on the emergence of a new Covid varia…
 
Making powerful and curative biologic therapies accessible to patients from all walks of life, and all corners of the globe, requires radically innovative thinking. On this episode of the Business of Biotech, Lumen Bioscience's Co-Founder and CEO Brian Finrow, J.D. and EVP of Production/Development Craig Behnke, Ph.D. discuss a novel approach: deve…
 
We all know the feeling of tiredness, but what causes the urge to sleep? Prof. Lior Appelbaum discusses the link between sleepiness and DNA damage, as sensed through the accumulation of a protein known as [...] The post 320 – Tiredness: Time for DNA Repair! first appeared on Talking Biotech Podcast.By Kevin M. Folta
 
Two CD47 targeting companies announced data updates from their clinical programs: Shattuk Labs and ALX Oncology. Both have suffered major stock price declines and in this episode, I go through the updates and discuss the potential of their molecules moving forward. Biogen cannot catch a break with the latest news continuing to contribute to new sto…
 
Wei-Chiang Chen, PhD is an Associate Director of Bioprocess Analytics in the Genome Medicine Unit at Sanofi, developing cell and gene therapies for areas of high unmet need. Prior to joining Sanofi, Wei-Chiang held positions at several large and small biotech companies including Biogen, Solid Biosciences, and Flexion Therapeutics. Additionally, he …
 
Dr. Claudia Schnugg is a researcher and curator with an interdisciplinary background in social sciences, business administration, cultural sciences, and the arts. She is a curator in the fields of art & science collaboration, organizational aesthetics, embodied knowledge, and artistic interventions. Partners and clients include interdisciplinary co…
 
Eric Venn-Watson holds an MBA from UCSD, was a Navy Flight Surgeon and is a current US Navy reservist. Steph Venn -Watson is a veterinary epidemiologist and public health scientist who has past experience working at the National Marine Mammal Foundation, DARPA, the CDC and WHO. For this episode I spent some time talking with Eric & Steph Venn-Watso…
 
As part of the multi-part series on Natural Killer Cell Therapies, this week on the podcast, Agustin discusses $AFMD. He explains the company's technology, pipeline, and recent catalysts. Additionally, he addresses some key questions including the monotherapy potential of AFM13 and AFM24 and where Affimed stands relative to other companies within t…
 
In business for just a decade, Akesobio's stats are mindboggling: 20 drug development programs, including 12 antibodies in clinical-stage development, six bi-specific antibodies (two at clinical stage), four antibodies with IND approvals from the FDA, and 22 clinical trials initiated. The company's CEO, Michelle Xia, Ph.D., sat down with the Busine…
 
T Cells are the body’snatural defenders against pathogens. In the past they have been reprogrammed to recognize specific surface antigens of cancer cells to attack and destroy them. The approach has worked well against [...] The post 319 – Reprogramming T-Cells for Immunotherapies first appeared on Talking Biotech Podcast.…
 
T Cells are the body’snatural defenders against pathogens. In the past they have been reprogrammed to recognize specific surface antigens of cancer cells to attack and destroy them. The approach has worked well against [...] The post 319 – Reprogramming T-Cells for Immunotherapies first appeared on Talking Biotech Podcast.…
 
On this bonus episode Agustin sits down and speaks with Robert Foster, current CEO of Hepion Pharmaceuticals ($HEPA) and previous co-founder of Aurinia Pharmaceuticals ($AUPH) . In this interview, they discuss multiple topics from Robert's previous experience at Aurinia and how he is leveraging those insights to guide drug development at Hepion. Th…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login